Search

everythinglearnresearchcommunity

for

Search:↓

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

RNase L suppresses regeneration in mammals.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

EGFR deficiency causes significant changes in skin cells and hair follicles.

Flow cytometry was effective in diagnosing metastatic breast cancer in a bone marrow sample.

Bone marrow and hair follicle cells help form skin tumors, suggesting new treatment targets.

Blocking a key energy pathway in human hair follicles can trigger stress responses that stop cell growth.

Anti-CD19 therapy may help treat SLE and NMOSD.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Beta-catenin boosts hair follicle cell growth by increasing c-myc expression.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Basal cell carcinoma behaves like hair follicles and targeting specific pathways may help treat it.

NXC736 significantly reduced hair loss in mice with alopecia areata.

RNase L hinders hair follicle regeneration by altering immune signals.

K31 can identify clear secretory cells in human sweat glands.

New imaging technology can show up to 40 different markers in hair loss tissue, helping to understand hair disease better.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

miRNAs in the Dlk1-Gtl2 region may improve lamb fur quality.

Chromosomal microarray analysis is important for diagnosing rare genetic variations and guiding treatment.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

CXCR2 in skin cells promotes tumor growth.

Measuring minimal residual disease on day 15 helps identify high-risk leukemia patients.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.